The editors of the New England Journal of Medicine allege that authors of a Merck-funded study of Vioxx in 2000
deleted relevant data before submitting the article for publication including that three additional patients in the clincal study suffered heart attacks. A table entitled "CV events" was deleted two days before submittal. On the financial side, the price of Merck stock dropped 3% today.
No comments:
Post a Comment